Detailed flow cytometric analysis of cellular DNA content was performed on neoplastic tissue from 33 patients with malignant common epithelial ovarian tumours in order to investigate the intratumoral stability of ploidy and proliferative fraction. There was a remarkable stability, both spatial and temporal, in the DNA pattern for any particular tumour. Of 24 tumours that were analysed in multiple areas tumour ploidy was found to be a stable marker in all but 3 cases where regional variations were evident. In 9 patients serial analyses were performed on tumour obtained either at initial diagnosis (6 patients) or second look laparotomy (3 patients) and then some time later (7-17 months) at relapse or death and in all cases the tumour ploidy remained unchanged. In addition, 10 ovarian carcinomas established in nude mice have maintained a DNA content during serial passage similar to that of the original implanted tumour. In contrast in 50% of tumours that were evaluable for S-phase analysis we demonstrated a considerable intratumoral variability in the S-phase fraction.
The flow cytometric determination of cellular DNA content has been shown to be of prognostic value in a number of tumour types (Bunn et al., 1982; Wolley et al., 1982) and we have recently reported that tumour ploidy was an independent prognostic variable and the major determinant of survival in patients with advanced ovarian cancer (Friedlander et al., 1983a) . The value of a single estimation of tumour ploidy would be clearly limited however if tumours commonly exhibited a variation in ploidy within different regions of the primary tumour or its metastases. Such variability has been reported in colonic cancer (Petersen et al., 1981) and small cell lung cancer (Vindelov et al., 1980) but there are no studies that have addressed the stability of cellular DNA content as determined with flow cytometry in ovarian tumours. We report the results of a study investigating the frequency of intratumoral heterogeneity of cellular DNA content and proliferative fraction (S-phase) in ovarian carcinomas.
Materials and methods
Tumour specimens for flow cytometric analysis and histological examination were obtained from 33 patients with ovarian carcinoma and multiple areas (mean 4, range 2-12) were biopsied from either the primary tumour alone (8 FIGO I and II tumours) Correspondence: M.L. Friedlander. Received 5 September 1983; accepted 10 October, 1983. or from the metastatic sites as well when the patient had advanced stage disease (16 patients). Particular attention was paid to include biopsies from the peripheral and central regions of a tumour mass when possible. In an additional 9 patients it was possible to analyse tumour ploidy sequentially on specimens obtained at either initial diagnosis (6 cases) or from residual tumour found at second look laparotomy (3 cases) and then at subsequent relapse. Operative specimens were received fresh from the operating theatres and tumour tissue was subdivided in the pathology department for flow cytometry and histological examination. DNA flow cytometry was usually performed within 2 h of operative removal of tumour from the patient but if not, samples were stored at -70°C prior to analysis. Ascitic or pleural fluid specimens were examined cytologically and flow cytometrically immediately following aspiration.
Flow cytometry DNA content All specimens were analysed on an ICP 22 flow cytometer (Ortho-Instruments, Westwood, MA). Specimens were processed and stained for DNA content with ethidium bromide and mithramycin in a single step staining technique that has been fully described elsewhere (Taylor, 1980) . Briefly, for solid tumours 250pd of a 1% Triton-x-100 solution containing 400pgml-1 ethidium bromide and 250y1 of a 1% triton solution containing 125 jig ml mithramycin and 75mM magnesium chloride were added to 2 ml of RPMI () The Macmillan Press Ltd., 1984 1640 medium containing 10% foetal calf serum. A 2ml aliquot of this staining solution plus 200p1 chicken red blood cells (CRBC; 106ml-1) were added to a small piece of tumour tissue (5mm x 5mm) in a petri dish and the tissue was finely disaggregated with scalpel blades. A further 2 ml of staining solution were added, the solution gently pipetted several times and the preparation filtered through an 80 pm nylon mesh filter. This preparation results in a suspension of isolated nuclei from which almost all cytoplasm has been removed. RNA-ase (ribonuclease Type IA, Sigma Chemical Company) was added to the suspension just prior to analysis to give a final concentration of l mgml-1.
Chicken red blood cells (CRBC) were used as an internal marker, as the ratio of the G1 DNA content of human diploid cells to the DNA content of CRBC is highly reproducible (2.9+0.17) under the staining conditions used (Taylor & Milthorpe, 1980) . Using this standard all the tumour specimens analysed contained a population of cells with a diploid DNA content. When this was the only cell population present the tumour was classified as diploid, while tumours which had evidence of an additional G1 peak were classified as aneuploid. Where in addition to the diploid G1 peak there was clear evidence of more than one aneuploid G1 peak the tumour was classified as multiploid. Ploidy was further quantitated by the DNA Index (DI) which represents the relative DNA content of the aneuploid G1 cells in comparison to diploid cells (Barlogie et al., 1980) . Thus, a DI of 1 is synonymous with a normal diploid DNA content. The mean coefficient of variation of the diploid or aneuploid G1 peak was 2.7% in all tumours studied (range 1.2-5.1).
In order to determine the sensitivity of the method of detecting an aneuploid tumour population, normal human lymphocytes (diploid) were admixed with an aneuploid ovarian cell line (DI= 1.59). Varying amounts of aneuploid cells were mixed with human lymphocytes to give a final cell concentration of 106ml-1 with an aneuploid cell content ranging from 0.5%-95%. The cells were stained with ethidium bromide and mithramycin as described above.
Proliferative fraction The proportion of cells in Sphase was estimated by computer analysis in 16 tumours using a planimetric method of analysis (Milthorpe, 1980 Figure 2 ) and this regional stability of DNA content was also evident in 2 multiploidal tumours ( Figure 3 ). The 3 exceptions (all Stage III tumours) included a tumour which was initially classified as diploid but had an additional tetraploid G1 peak demonstrated in one region and two aneuploid tumours which showed regional variations of aneuploidy ( Figure 4 ). Only one of these tumours had concomitant regional histological differences which correlated with the ploidy variations (a mixed epithelial carcinoma with adenosquamous and typical serous carcinoma in different areas).
Although the DI was stable in different areas of most tumours there were nevertheless often regional variations (for examples, see Figure 4 ) in the actual proportion of aneuploid to diploid cells. We determined the sensitivity of flow cytometry in detecting aneuploid populations and under controlled conditions demonstrated that a 1% concentration of aneuploid cells admixed with normal human lymphocytes could be identified ( Figure 5 ). between the first and second DNA analysis of 9 months (range, 7-15 months). Two patients initially had diploid tumours and 7 had aneuploid tumours and the DI of all tumours remained unchanged at the time of relapse or death (Table I) .
Xenografted ovarian tumours Ten epithelial ovarian carcinomas were established directly in nude mice and histological examination and DNA analyses were performed on tumour tissue just prior to implantation and repeated at each subsequent passage. The DI (Table II) and histological features have remained essentially unchanged during the serial passage of all tumours to date (median time= 12 months). Channel number Figure 3 Demonstration of stability of DNA content in a multiploid tumour. There is evidence of 2 aneuploid clones in both the primary tumour and omental metastases. Note the resolving power of the instrument in discriminating the 2 diploid peaks. Channel no., relative fluorescence intensity (DNA content). Ordinate, number of cells. major determinant of survival in advanced ovarian cancer (Friedlander et al., 1983a) and similar findings have been reported in other malignancies (Bunn et al., 1982; Wolley et al., 1982) . There is however, some evidence that regional variations in tumour ploidy are common in colonic carcinomas (Petersen et al., 1981) and small cell lung cancer (Vindelov et al., 1980) and the heterogeneity of such tumours casts doubts on the value of a single estimation of ploidy as a prognostic index for all tumour types. We have therefore studied the stability of cellular DNA content in common epithelial ovarian cancer.
While ovarian tumours as a group are widely heterogeneous with respect to DNA content (Atkin, 1970; Friedlander et al., 1983b) (Atkin, 1970) . Further evidence of the stability of cellular DNA content in epithelial ovarian cancer is provided by finding that in ovarian tumours established in nude mice the DI remains unchanged during serial passage. The mean variation of the DI before and after passage in nude mice was 4.5% (range, 0-10%). This is in keeping with the variation that can be expected by possible staining and instrumental variation (Taylor & Milthorpe, 1980) . It was possible to determine the stability of cellular DNA content during tumour progression in 9 patients by analysing tumour specimens obtained at initial diagnosis or at a second look laparotomy and then again 7-17 months later at the time of relapse or death and in all cases the DI remained unchanged. All these patients had initially responded to chemotherapy with cis-platinum and/or chlorambucil and had later relapsed. It is interesting that there was a reappearance of clones with the same DNA content as that found prior to treatment, which suggests some stability of the genome. There could however be chromosomal variability associated with disease progression but masked either by minor changes undetectable with flow cytometry (Barlogie et al., 1977) or because chromosomal number variability may be due to a DNA packaging defect which would not be reflected by a change in the DNA content (Kraemer et al., 1971) . Only a small number of cases have been reported where serial karyotyping and banding studies have been performed following the progression of ovarian tumours and such studies show that the karyotype remains basically unchanged during tumour progression with changes, when present, representing a variation in the theme already observed in the original tumours (Atkin, 1970; MacKillop et al., 1983; Sandberg, 1982) .
While the DI remains constant within a primary tumour and its metastases the proportion of aneuploid cells often varies from one region to another. This feature has been interpreted by some (Nervi et al., 1982) as evidence of intratumoral heterogeneity but it is likely that these variations reflect different degrees of admixing of normal diploid cells with aneuploid tumour cells rather than changes of biological significance. We cannot rule out entirely the possibility that cells with a diploid DNA content in tumours with bimodal DNA distributions could represent an additional tumour clone but a number of studies have shown that in these circumstances the diploid cells usually represent normal cells (Barlogie et al., 1978; Perez et al., 1981) . We determined the sensitivity of flow cytometry to detect aneuploid tumour cells admixed with normal cells under controlled conditions and showed that as low as a 1 % content of tumour cells could be detected. However, for practical purposes, we suggest the limit of detection of an aneuploid cell population is between 5% and 10% of the cells analysed due to the presence of background debris and the possible masking effect of the S-phase and G2 + M components of diploid cells. Histological examination of all specimens analysed is therefore necessary to ensure that they contain adequate and representative portions of tumour tissue. This assumes particular importance in diploid tumours where the finding may have important prognostic implications, as these tumours have a more favourable natural history than aneuploid tumours (Atkin, 1970; Bunn et al., 1982 , Friedlander et al., 1983b Wolley et al., 1982) . The actual degree of aneuploidy (i.e. DI of tumour) or the presence of multiploidy has not been demonstrated to date to be of significance and although it has been suggested by some that multiploid tumours may have a more aggressive natural history (Taylor et al., 1983; Vindelov et al., 1980) , we could not confirm this in patients with advanced ovarian cancer. All 3 patients who had regional variations in ploidy in this study relapsed within 6 months of diagnosis and it is possible that an unstable DNA content identifies high risk patients.
The S-phase as determined flow cytometrically has been reported to be a reflection of the aggressiveness of tumour behaviour and to be of prognostic significance (Costa et al., 1981) . The Sphase can be determined in all diploid tumours but (Dosik et al., 1980) , while aneuploid tumours could have a higher S-phase because of the presence of diploid doublets and tetraploid normal cells. In this study we found that up to 50% of tumours showed a significant regional variation in the S-phase fraction (>40% variation in different areas). The reasons for this variability are not known but could relate either to different proliferative states among tumour cells in different nutritional environments, or to variable contamination of tumour cells by normal non-cycling cell populations. The value of a single S-phase estimation is therefore clearly limited in the light of these findings, as are data relating to the prognostic value of S-phase in ovarian cancer.
We conclude that DNA content is a stable feature in most cases of epithelial ovarian cancer exhibiting constancy within the primary tumour, its metastases and during subsequent tumour progression. On the other hand, the S-phase fraction is often subject to considerable intratumoral variation. These results cannot necessarily be extrapolated to other tumour types where similar studies are required to establish the representative value of a single estimation of tumour DNA content or proliferative fraction.
